Birth and Death of Choriocapillaris.
Birth and Death of Choriocapillaris.
批准号:
8290655
负责人:
Gerard Anthony Lutty
金额:
$48.84万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-09-01 至 2017-04-30
关键词:
AffectAgeAlbuminsArchitectureBirthBlood VesselsBlood capillariesBruch&aposs basal membrane structureCause of DeathCaveolaeCell DeathCessation of lifeChargeChoroidChronologyCollectionDefectDepositionDevelopmentDrusenEndothelial CellsEpithelialExcisionExudative age-related macular degenerationEyeFunctional disorderGoldGrantHumanIn VitroKnock-outKnowledgeLabelLipidsLipoproteinsLobularManuscriptsMembraneMusNonexudative age-related macular degenerationNutrientOxygenPhotoreceptorsPositioning AttributePropertyProteinsPublishingRespiratory DiaphragmRetinaRetinalRetinal DegenerationSerumSerum ProteinsSideSpecimenStructure of retinal pigment epitheliumSystemTherapeuticThird Pregnancy TrimesterTight JunctionsTimeToxic effectTransmission Electron MicroscopyTransport ProcessUp-RegulationVascular Endothelial Growth Factorsagedalpha 2-Glucoproteinscapillarycaveolin 1coated pitcohortcrosslinkcytotoxicglycationin vivomacromoleculemonolayernanoparticleneovascularpreventvasculogenesiswasting
中文摘要
描述(申请人提供):脉络膜毛细血管(CC)是一种有窗的小叶血管系统,为RPE和光感受器提供所有的氧气和血清营养物质。我们详细阐述了在上一次资助期间,人类CC是通过血管生成而诞生的,而CC在湿性和干性AMD中死亡。在干性AMD中,CC细胞的死亡与邻近RPE的丢失有关。在湿性AMD中,CC的丢失发生在脉络膜新生血管膜(CNV)形成之前,这一点至今无法解释。我们观察到干性和湿性AMD患者CC周围的血清蛋白浓度较高。这种积累的原因和这些蛋白对CC的影响尚不清楚。虽然假设CC为RPE和光感受器提供营养物质,并清除废物,但确切的运输机制尚不清楚。拟议的研究将描述CC通过开窗、洞穴和涂层坑的正常运输机制。这些机制将使用确定大小的金纳米颗粒、标记的血清蛋白和标记的血清脂类进行评估。我们将通过使用缺乏小窝(敲除小窝系统中的主要成分Cav-1)或开窗(RPE产生的VEGF被敲除或中和)或RPE过度表达VEGF的小鼠,或产生基底层沉积的小鼠,来确定CC转运的失调是否影响蛋白质的积累。拟议的研究将确定Bruchs膜沉积对CC传输的影响以及CC传输缺陷对沉积形成的影响。我们假设CC转运功能障碍导致了我们观察到的脉络膜中血清蛋白的积聚,这对CC是有毒的,可能是CC在AMD中死亡的原因。我们将评估血清蛋白(白蛋白、C反应蛋白和α-2巨球蛋白)在体外对脉络膜内皮细胞(CEC)的毒性作用,并确定这些血清蛋白是否会导致CEC紧密连接的丧失、小凹数量的变化或开窗。这也被认为是CC功能障碍与AMD有关。我们的初步研究表明,窗孔的丢失与Bruchs膜沉积和RPE丢失有关。在Greg Hageman为透射电子显微镜准备的一大批AMD眼睛中,我们将确定人类AMD中的CC窗口、凹陷、涂层凹坑和/或紧密连接是否发生变化,以及基底沉积、玻璃体和RPE丢失与这些变化的关联。总而言之,这项提议将定义CC向视网膜供应营养物质所使用的正常运输过程。我们还将确定这些传输过程在AMD中是否发生了变化。我们将确定脉络膜中随年龄积累的血清蛋白是否与我们在AMD中观察到的CC转运功能障碍和CC死亡有关。我们将研究血管内皮生长因子的降低或升高如何改变CC的转运。这一关于CC转运及其在AMD中的变化的新知识将对开发新的系统治疗纳米粒以预防AMD的视网膜变性和CNV具有非常宝贵的价值。
公共卫生相关性:这项研究将确定脉络膜毛细血管(CC)如何将营养物质运输到视网膜色素上皮(RPE)和光感受器,以及在存在太少或太多VEGF的情况下,CC运输系统是否受到失调。这将在小鼠身上完成,使用统一的大小和带电的金纳米颗粒,并标记白蛋白和脂蛋白来评估凹陷、开窗、涂层凹陷和紧密连接。CC转运也将在没有开窗和凹陷的小鼠身上进行评估,或者在Bruchs膜上有沉积物。这些结果将与一组具有良好特征的AMD和老年受试者的透射电子显微镜进行比较。这些研究将确定CC转运的机制以及它们在AMD中是如何受到影响的,这两项都是未知的。
英文摘要
DESCRIPTION (provided by applicant): The choriocapillaris (CC) is a lobular, fenestrated vasculature that provides all of the oxygen and serum nutrients to the RPE and photoreceptors. We have elaborated the birth of human CC by hemo-vasculogenesis and the death of CC in wet and dry AMD in the last grant period. In dry AMD, CC cell death is related to loss of adjacent RPE. In wet AMD, loss of CC occurs in advance of choroidal neovascular membrane (CNV) formation, which is unexplained to date. We have observed high concentrations of serum proteins around CC in dry and wet AMD. The reason for this accumulation and influence of these proteins on CC is unknown. Although it is assumed that CC provides the nutrients for RPE and photoreceptors and removes waste, the exact mechanisms of transport are unknown. The proposed studies will characterize CC's normal transport mechanisms via fenestrations, caveolae, and coated pits. These mechanisms will be evaluated using gold nanoparticles of defined sizes, tagged serum proteins, and tagged serum lipids. We will determine if dysregulation in CC transport affects protein accumulation by using mice lacking caveolae (knock out cav-1, the major component in the caveolae system), or fenestrations (RPE-produced VEGF knocked out or neutralized), or mice with RPE over expressing VEGF, or producing basal laminar deposits. The proposed studies will determine the effects of Bruchs membrane deposits on CC transport and the effects of CC transport defects on deposit formation. We hypothesize that dysfunction in CC transport results in the serum protein accumulation in choroid we observe, which is toxic to CC and may be the reason that CC die in AMD. We will evaluate the toxicity of serum proteins (albumin, CRP, and alpha-2 macroglobulin with and without glycation) on choroidal endothelial cells (CEC) in vitro and determine if those serum proteins cause loss of tight junctions, changes in numbers of caveolae or fenestrations in CEC. It is also assumed that CC dysfunction is involved in AMD. Our preliminary studies demonstrated that loss in fenestrations is associated with Bruchs membrane deposits and RPE loss. In a large collection of AMD eyes that Greg Hageman has prepared for TEM, we will determine if CC fenestrations, caveolae, coated pits and/or tight junctions change in human AMD and the association of basal deposits, drusen, and RPE loss with these changes. In conclusion, this proposal will define the normal transport processes used by CC to supply nutrients to retina. We will also determine if these transport processes are altered in AMD. We will determine if serum proteins that accumulate with age in choroid contribute to dysfunction in CC transport and the death of CC we have observed in AMD. We will investigate how reduced or elevated VEGF changes CC transport. This new knowledge of CC transport and how it changes in AMD will be invaluable in developing new systemic therapeutic nanoparticles for preventing retinal degeneration and CNV that occurs in AMD.
PUBLIC HEALTH RELEVANCE: This study will determine how the choriocapillaris (CC) transports nutrients to retinal pigment epithelium (RPE) and photoreceptors and if the CC transport systems are dysregulated in the presence of too little or too much VEGF. This will be accomplished in mice using uniform size and charge gold nanoparticles, and labeled albumin and lipoprotein to evaluate caveolae, fenestrations, coated pits, and tight junction. CC transport will also be evaluated in mice lacking fenestrations and caveolae, or with deposits on Bruch's membrane. These results will be compared to transmission electron microscopy of a well-characterized cohort of AMD and aged subjects. These studies will determine mechanisms of CC transport and how they are affected in AMD, both of which are unknown.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Potential target molecules for ischemic retinopathies
-
批准号:8126322
-
项目类别:
-
资助金额:$35.07万
-
财政年份:2007
-
负责人:Gerard Anthony Lutty
-
依托单位:
Birth and Death of Choriocapillaris.
-
批准号:7454181
-
项目类别:
-
资助金额:$35.11万
-
财政年份:2006
-
负责人:Gerard Anthony Lutty
-
依托单位:
Birth and Death of Choriocapillaris.
-
批准号:8656115
-
项目类别:
-
资助金额:$45.51万
-
财政年份:2006
-
负责人:Gerard Anthony Lutty
-
依托单位:
Birth and Death of Choriocapillaris.
-
批准号:7627254
-
项目类别:
-
资助金额:$35.83万
-
财政年份:2006
-
负责人:Gerard Anthony Lutty
-
依托单位:
Birth and Death of Choriocapillaris.
-
批准号:7280323
-
项目类别:
-
资助金额:$35.49万
-
财政年份:2006
-
负责人:Gerard Anthony Lutty
-
依托单位:
Birth and Death of Choriocapillaris.
-
批准号:7860537
-
项目类别:
-
资助金额:$35.47万
-
财政年份:2006
-
负责人:Gerard Anthony Lutty
-
依托单位:
Birth and Death of Choriocapillaris.
-
批准号:8459368
-
项目类别:
-
资助金额:$45.18万
-
财政年份:2006
-
负责人:Gerard Anthony Lutty
-
依托单位:
Birth and Death of Choriocapillaris.
-
批准号:7144518
-
项目类别:
-
资助金额:$36.47万
-
财政年份:2006
-
负责人:Gerard Anthony Lutty
-
依托单位:
MECHANISM OF SICKLE CELL RETENTION IN THE RETINAL VASCULATURE
-
批准号:6646652
-
项目类别:
-
资助金额:$17.52万
-
财政年份:2002
-
负责人:Gerard Anthony Lutty
-
依托单位:
MECHANISM OF SICKLE CELL RETENTION IN THE RETINAL VASCULATURE
-
批准号:6593858
-
项目类别:
-
资助金额:$17.52万
-
财政年份:2002
-
负责人:Gerard Anthony Lutty
-
依托单位:
Nanoparticle delivery of antiangiogenic genes
-
批准号:6417941
-
项目类别:
-
资助金额:$16.35万
-
财政年份:2001
-
负责人:Gerard Anthony Lutty
-
依托单位:
Nanoparticle delivery of antiangiogenic genes
-
批准号:6605691
-
项目类别:
-
资助金额:$16.35万
-
财政年份:2001
-
负责人:Gerard Anthony Lutty
-
依托单位:
MECHANISM OF SICKLE CELL RETENTION IN THE RETINAL VASCULATURE
-
批准号:6449395
-
项目类别:
-
资助金额:$17.52万
-
财政年份:2001
-
负责人:Gerard Anthony Lutty
-
依托单位:
Nanoparticle delivery of antiangiogenic genes
-
批准号:6518747
-
项目类别:
-
资助金额:$16.35万
-
财政年份:2001
-
负责人:Gerard Anthony Lutty
-
依托单位:
MECHANISM OF SICKLE CELL RETENTION IN THE RETINAL VASCULATURE
-
批准号:6325942
-
项目类别:
-
资助金额:$12.16万
-
财政年份:2000
-
负责人:Gerard Anthony Lutty
-
依托单位:
MECHANISM OF SICKLE CELL RETENTION IN THE RETINAL VASCULATURE
-
批准号:6109882
-
项目类别:
-
资助金额:$12.16万
-
财政年份:1999
-
负责人:Gerard Anthony Lutty
-
依托单位:
MECHANISM OF SICKLE CELL RETENTION IN THE RETINAL VASCULATURE
-
批准号:6272811
-
项目类别:
-
资助金额:$12.11万
-
财政年份:1998
-
负责人:Gerard Anthony Lutty
-
依托单位:
Animal Models Module
-
批准号:10020646
-
项目类别:
-
资助金额:$8.13万
-
财政年份:1997
-
负责人:Gerard Anthony Lutty
-
依托单位:
Animal Models Module
-
批准号:10700929
-
项目类别:
-
资助金额:$8.13万
-
财政年份:1997
-
负责人:Gerard Anthony Lutty
-
依托单位:
Animal Models Module
-
批准号:10256788
-
项目类别:
-
资助金额:$8.13万
-
财政年份:1997
-
负责人:Gerard Anthony Lutty
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: